NCT06166459View on ClinicalTrials.gov

Yao Strategy for the Treatment of de Novo Medina 0,1,0 or 0,0,1 Bifurcation Lesion

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 22, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2026

Conditions
Coronary Artery DiseaseBifurcation Lesion
Interventions
PROCEDURE

Drug-coated balloon combined with provisional drug-eluting stent implantation

(1) DCB combined with provisional DES implantation 1-2 mm distally to the ostium lesion whenever this was required (DCB+pDES strategy). (2) DES implantation 1-2 mm distally to the ostium lesions followed by DCB treatment (DES+DCB strategy).

All Listed Sponsors
lead

Xuzhou Third People's Hospital

OTHER

NCT06166459 - Yao Strategy for the Treatment of de Novo Medina 0,1,0 or 0,0,1 Bifurcation Lesion | Biotech Hunter | Biotech Hunter